Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

U.S. DoD recommends funding development of STA-9584 for prostate cancer

Nov. 23, 2010

D-3263 HCl may stabilize disease in patients with advanced prostate cancer

Nov. 23, 2010

University of Michigan describes new 1,4-benzodiazepinone derivatives

Nov. 22, 2010

Immunovaccine's phase I/II DPX-Survivac testing will target ovarian cancer

Nov. 22, 2010

Spanish scientists present new inhibitors of PI3K/mTOR

Nov. 22, 2010

New HIF-1-alpha inhibitor P-2630 demonstrates oncolytic activity in vivo

Nov. 22, 2010

Lilly describes activity of LY-2606368, now in phase I testing

Nov. 22, 2010

BioSante Pharma sells Cold Genesys rights to its oncolytic virus technology

Nov. 22, 2010

Reolysin to enter phase I trial in pediatric patients with solid tumors

Nov. 19, 2010

Astex Therapeutics claims new fibroblast growth factor receptor inhibitors

Nov. 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...